Dr. Thomas George Hill graduated from Western University (Canada) with a BSc (Hons) in Biology after spending a year at the University of Ottawa. Subsequently, he obtained an MSc in Biomedical and Molecular Sciences Research from King’s College London. He then completed his PhD at King’s College London. In October 2018, he joined the University of Oxford as a Novo Nordisk Postdoctoral Research Fellow. His research area was assessing the regulation of islet δ-cell secretion in health and disease.

Dr. David Joseph Hill is a renowned professor in the Departments of Medicine, Physiology & Pharmacology, and Pediatrics at Western University, where he holds the Lawson Professorship in Diabetes Research. He currently serves as the Scientific Director of the Lawson Health Research Institute and as the Integrated Vice President of Research for both the London Health Sciences Centre and St. Joseph’s Health Care London. Dr. Hill received his education from the University of Nottingham, Worcester College, and the and the University of Oxford. He is a prolific author, having published more than 200 scientific papers, and he maintains an active program in diabetes research and progenitor cell biology. Dr. Hill has received numerous accolades for his work, including Diabetes Canada’s Frederick G. Banting Award, the Medal of the Society for Endocrinology from the UK, and the Jorgen Pederson Medal of the Diabetic Pregnancy Study Group. In 2011, he was inducted as a Fellow of the Canadian Academy of Health Sciences (CAHS). Dr. Hill’s research is primarily focused on developing new insulin-producing beta cells in the pancreas as a means of reversing diabetes.